ATHE insider trading — Alterity Therapeutics Ltd
Over the last 90 days, insiders at Alterity Therapeutics Ltd (ATHE) made 1 open-market purchase worth $24K and 0 open-market sales worth $0, making them net buyers by $24K. The largest purchase was by Marks Peter Ashley (Director), who bought 47,620 shares for $24K on Aug 31, 2026.
Updated Oct 16, 2026.
Recent ATHE insider transactions
Every Form 4 filed by Alterity Therapeutics Ltd officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Marks Peter Ashley | Director | P · Purchase | Indirect | 47,620 | $0.50 | $24K | Form 4 |
ATHE insider trading FAQ
Are insiders buying ATHE stock?
Yes. In the last 90 days, Alterity Therapeutics Ltd insiders made 1 open-market purchase totaling $24K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ATHE?
Recent buyers: Marks Peter Ashley.
Where does ATHE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.